Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, April 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 22,144 followers.

Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy https://t.co/3nMgv0wWPC #allergy #feedly

20 Apr 2020

Reply Repost Favourite

RT @ImmunAllergyBMC: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral…

20 Apr 2020

Reply Repost Favourite

RT @ImmunAllergyBMC: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral…

19 Apr 2020

Reply Repost Favourite

RT @ImmunAllergyBMC: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral…

19 Apr 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.